Medical Pavilion I & II at National Harbor Exemplify Industry Shift to Preference of Adaptable and Community-Integrated Medical Spaces NATIONAL HARBOR, MD / ACCESS Newswire / October 30, 2025 / The ...

The AMCP Nexus meeting addressed healthcare policy issues, including PBM reform, Medicaid reform, and the Inflation Reduction ...

AAVivo, Inc., a pioneering biotechnology company developing novel, precision targeted biotherapeutics to enable in vivo ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced ...

Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells ...

In January, Tess, a Mathematics Secondary Education major, lacrosse team captain, student tutor, and Student Athletic ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that results from the Phase III ...

Community Conversation on Credit Equity hosted by Maryland Bankers Association and Coppin State University to improve financial literacy and opportunities.

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

Presentations to highlight ongoing clinical and translational research across PDS Biotechnology’s immunotherapy platforms ...

Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced a ...